Induction Healthcare Group PLC Notice of AGM (2285K)
20 Dezembro 2022 - 4:00AM
UK Regulatory
TIDMINHC
RNS Number : 2285K
Induction Healthcare Group PLC
20 December 2022
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Notice of AGM
Induction (AIM: INHC), a leading digital health platform driving
transformation of healthcare systems worldwide, announces that the
Notice of Annual General Meeting ("AGM") and associated Form of
Proxy are now available on the Company's website and have been
posted to those shareholders who have opted out of electronic
communications (together with a paper copy of the Annual Report)
.
The documents are available here:
https://inductionhealthcare.com/investors/financial-reports-and-publications/
The Company's AGM will be held at 50 Liverpool Street, London
EC2M 7PY at 9.30am (GMT) on Wednesday 11 January 2023.
Shareholders are strongly encouraged to complete and return the
Form of Proxy in accordance with the instructions set out, to the
Company's registrars, Equiniti Limited, Aspect House, Spencer Road,
Lancing, West Sussex, BN99 6DA, as soon as possible but in any
event so as to arrive no later than 9.30am GMT on Monday 9 January
2023.
Alternatively, eligible shareholders who hold their shares in
the Company in uncertificated form in CREST may use the CREST Proxy
Voting Service, details in respect of which are contained in the
notes to the notice of the AGM. Electronic Proxy Appointment is
also available for this meeting. To use this facility shareholders
must visit www.sharevote.co.uk where details of the procedure are
shown. Details on how to lodge votes electronically are contained
within the notes to the notice of the AGM.
The results of voting on the resolutions will be announced via a
regulatory information service and posted on the Company's website
as soon as practicable after the AGM.
In order to give shareholders a chance to engage in a meaningful
dialogue with the Company's management, shareholders are encouraged
to email Induction's Company Secretary at
legal@inductionhealthcare.com with any questions on the business of
the AGM or the Report and Accounts in advance of the meeting
stating your name (as printed on your form of proxy). The questions
will be collated and a representative sample will be selected to be
answered on the Company's website at
https://inductionhealthcare.com/ as soon as practicable after the
conclusion of the AGM. The Company will also endeavour to provide
answers directly to shareholders who submitted the questions as
soon as reasonably practical.
ENQUIRIES
Induction Via Walbrook PR Ltd: induction@walbrookpr.com
James Balmain, Chief Executive Officer
Christopher Samler, Non-Executive
Chair
Singer Capital Markets (Nominated
Adviser and Broker) +44 (0)20 7496 3000
Philip Davies / Kailey Aliyar
Walbrook PR Ltd induction@walbrookpr.com
Alice Woodings / Paul McManus Mob: +44 (0)7407 804 654 / +44(0)7980
541 893
About Induction - www.inductionhealthcare.com
Induction (AIM: INHC) Induction delivers a suite of software
solutions through a single integrated platform that transforms care
delivery. Our system-wide applications help healthcare providers
and administrators to deliver care at any stage remotely as well as
face-to-face - giving the communities they serve greater
flexibility, control and ease of access. Purpose-built for
integration with leading Electronic Medical Record (EMR) platforms,
our products offer immediate stand-alone value that becomes even
greater when integrated with pre-existing systems.
Used at scale by national and regional healthcare systems, as
well non-health government services, our applications are relied
upon by hundreds of thousands of clinicians and millions of
patients across almost every hospital in the British Isles.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOAFFFFWUEESEEE
(END) Dow Jones Newswires
December 20, 2022 02:00 ET (07:00 GMT)
Induction Healthcare (LSE:INHC)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Induction Healthcare (LSE:INHC)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024